Tardive Dyskinesia and intellectual disability: An examination of demographics and topography in adults with dual diagnosis and atypical antipsychotic use
| Autor: | Johnny L. Matson, Daniene Neal, Sara Mahan, Jay W. Bamburg, Julie A. Hess, Jill C. Fodstad, Jodie Holloway |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Adult
Male Dyskinesia Drug-Induced medicine.medical_specialty Bipolar Disorder Adolescent Multiple disabilities medicine.drug_class Population Stereotypic Movement Disorder Atypical antipsychotic Tardive dyskinesia Severity of Illness Index Residential Facilities Young Adult Predictive Value of Tests Risk Factors Intellectual Disability Intellectual disability Developmental and Educational Psychology medicine Humans Bipolar disorder Psychiatry education Aged Aged 80 and over Depressive Disorder Psychotropic Drugs education.field_of_study Middle Aged medicine.disease Clinical Psychology Psychotic Disorders Dyskinesia Dual diagnosis Female medicine.symptom Psychology Antipsychotic Agents Clinical psychology |
| Zdroj: | Research in Developmental Disabilities. 31:750-759 |
| ISSN: | 0891-4222 |
| DOI: | 10.1016/j.ridd.2010.01.017 |
| Popis: | Atypical antipsychotic medications are commonly used in large-scale residential care facilities for adults with developmental disabilities. While the benefits of this class of psychotropics are noted, debate exists whether the side effect profile of these medications outweigh their therapeutic benefit, especially in those who use them long-term. Tardive Dyskinesia (TD) is a movement disorder often caused by a history of neuroleptic use which can cause deleterious effects. Due to the seriousness of TD and the impact on an individual's quality of life, it is necessary to identify predisposing factors for this condition in a population of adults with intellectual and developmental disabilities. The current study seeks to expand the literature related to TD and atypical antipsychotic medication utilizing a measure of medication side effects, the Matson Evaluation of Drug Side Effects (MEDS). Results and implications for assessment and practice are discussed. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect